{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:47:01Z","timestamp":1786978021807,"version":"build-2736575974"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T00:00:00Z","timestamp":1423008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T00:00:00Z","timestamp":1423008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1002\/jcph.456","type":"journal-article","created":{"date-parts":[[2015,1,3]],"date-time":"2015-01-03T05:58:27Z","timestamp":1420264707000},"page":"671-679","source":"Crossref","is-referenced-by-count":28,"title":["Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin"],"prefix":"10.1002","volume":"55","author":[{"given":"Grace","family":"Chen","sequence":"first","affiliation":[{"name":"Takeda Development Center AmericasOne Takeda ParkwayDeerfieldILUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Takeda Development Center AmericasOne Takeda ParkwayDeerfieldILUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Serenko","sequence":"additional","affiliation":[{"name":"Takeda Development Center AmericasOne Takeda ParkwayDeerfieldILUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.7.795"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.1.59"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02543.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1546"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.100912"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318224996e"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.08.019"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1737"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.110456"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05786blu"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03190876"},{"key":"e_1_2_6_13_1","unstructured":"Brintellix [package insert]. Deerfield IL: Takeda Pharmaceuticals America Inc.; 2013."},{"key":"e_1_2_6_14_1","unstructured":"Summary of Product Characteristics: Brintellix H. Lundbeck A\/S2013.http:\/\/www.ema.europa eu\/docs\/en_GB\/document_library\/EPAR_\u2010_Product_Information\/human\/002717\/WC500159449.pdf."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2012.00886.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.044610"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm101459g"},{"key":"e_1_2_6_18_1","first-page":"47","article-title":"In vitro and in vivo effects for the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets [abstract]","volume":"16","author":"Westrich L","year":"2012","journal-title":"Int J Psychiatry Clin Pract"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.189068"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7329.71"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.194S"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.220S"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1_suppl.228S"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190012448310"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/tx00025a009"},{"key":"e_1_2_6_26_1","unstructured":"Food and Drug Administration. Guidance for Industry. Drug interaction studies\u2014study design data analysis and implications for dosing and labeling.http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM292362.pdf."},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.31.1371"},{"key":"e_1_2_6_28_1","unstructured":"Prozac [package insert]. Indianapolis IN: Eli Lilly and Company;2011."},{"key":"e_1_2_6_29_1","unstructured":"Cymbalta [package insert]. Indianapolis IN: Eli Lilly and Company;2012."},{"key":"e_1_2_6_30_1","unstructured":"European Medicines Agency. Brintellix\u2014EMEA\/H\/C\/0027172014.http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002717\/WC500159449.pdf."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.456","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.456","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcph.456","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jcph.456\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T09:04:12Z","timestamp":1657789452000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,4]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.1002\/jcph.456"],"URL":"https:\/\/doi.org\/10.1002\/jcph.456","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,4]]}}}